Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M111Revenue $M0Net Margin (%)0Z-Score-8.9
Enterprise Value $M77.5EPS $-1.3Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book4.510-y EBITDA Growth Rate %-10.1Quick Ratio16.1Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %1.3Current Ratio16.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-76.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)4ROE % (ttm)-138.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M21.9ROI % (ttm)-7,524.8Gross Margin Increase y-yN

Gurus Latest Trades with GALT

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GALTGeorge Soros 2014-06-30 Sold Out -0.01%$10.23 - $14.81
($12.43)
$ 5.15-59%Sold Out0
GALTGeorge Soros 2014-03-31 Buy 0.01%$8.025 - $18.3
($14.02)
$ 5.15-63%New holding, 48200 sh.48,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GALT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
GALT George Soros 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


GALT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Greenberg ArthurDirector 2014-08-19Buy1,000$4.5612.94view
FREEMAN KEVIN DDirector 2014-08-15Buy1,000$4.79.57view
TRABER PETER GPresident and CEO 2014-08-14Buy4,000$4.4615.47view
CALLICUTT JACK WCFO 2014-08-14Buy1,000$4.5513.19view
TRABER PETER GPresident and CEO 2014-08-13Buy1,000$4.4216.52view
Prelack StevenDirector 2014-04-11Sell6,000$11.84-56.5view
10X Fund, L.P.10% Owner 2014-01-13Sell100,000$14.84-65.3view
CZIRR JAMES CExecutive Chairman 2014-01-13Sell100,000$14.84-65.3view
Martin Rod DDirector 2014-01-13Sell100,000$14.84-65.3view
MAULDIN JOHN FDirector 2014-01-02Buy618$8.01-35.71view

Press Releases about GALT :

    Quarterly/Annual Reports about GALT:

    News about GALT:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Nasdaq stocks posting largest percentage increases Sep 30 2014
    Trick Play: Beware of Insiders Trying to 'Paint the Tape' Sep 30 2014
    GALECTIN 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General... Sep 26 2014
    EQUITY ALERT: Rosen Law Firm Reminds Galectin Therapeutics, Inc. Investors of Important September... Sep 26 2014
    Galectin Therapeutics Elects Gilbert S. Omenn, M.D., Ph.D., a Leading Cancer Researcher, to Its... Sep 24 2014
    GALECTIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers Sep 24 2014
    SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Galectin... Sep 22 2014
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Sep 22 2014
    MLV & Co Has Positive Outlook On Galectin Therapeutics Inc Sep 16 2014
    GALECTIN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds... Sep 15 2014
    Galectin Therapeutics Announces Issuance of U.S. Patent for GR-MD-02 in Diabetic Nephropathy Sep 15 2014
    GALECTIN THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Sep 15 2014
    GALECTIN THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 12 2014
    DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Galectin Therapeutics Inc. Of... Sep 12 2014
    SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Galectin... Sep 10 2014
    Galectin Therapeutics to Present at Aegis Capital Corporation 2014 Healthcare and Technology... Sep 10 2014
    Hagens Berman Reminds Investors in Galectin Therapeutics, Inc. of the Sept. 29, 2014 Lead Plaintiff... Sep 08 2014
    SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Galectin... Sep 05 2014
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From... Sep 04 2014
    Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In... Aug 29 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK